SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-287321
Filing Date
2017-09-18
Accepted
2017-09-18 16:12:56
Documents
1
Group Members
BCIP LIFE SCIENCES ASSOCIATES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d266616dsc13da.htm SC 13D/A 42688
  Complete submission text file 0001193125-17-287321.txt   44189
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Subject) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87866 | Film No.: 171090045
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
Bain Capital Life Sciences Fund, L.P. (Filed by) CIK: 0001687968 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A